Business
After nearly two decades in big pharma, Lars van der Veen made the leap to entrepreneurship, co-founding iOnctura, a clinical-stage Biotech developing low-disruption therapies that target the tumour-stroma crosstalk to improve patient outcomes in cancer.
In this episode of Careers in Discovery, Lars shares his journey from medicinal chemist to Biotech CSO, the lessons he learned building a company from scratch, and why taking the leap into Biotech offered him the chance to have real impact. He also talks about the science behind iOnctura’s approach, how focusing on quality of life - not just survival - is shaping the future of oncology, and why every founder needs a plan B.
More Episodes
Samantha Bailey-Bucktrout, Akamis Bio
2023-11-29
45
2023-11-29
45
Beverley Carr, Amphista Therapeutics
2023-11-08
49
2023-11-08
49
Janette Thomas, Five Alarm Bio
2023-10-25
38
2023-10-25
38
Dan Williams, SynaptixBio
2023-10-04
41
2023-10-04
41
Matthew Duchars, CHAIN Biotech
2023-09-27
32
2023-09-27
32
Orla Cunningham, Granular Therapeutics & Ultrahuman 8
2023-09-13
62
2023-09-13
62
Rebecca Godfrey, ExpressionEdits
2023-08-16
37
2023-08-16
37
Jenny Barnett, Monument Therapeutics & Five Lives
2023-08-09
33
2023-08-09
33
Paul Thompson, Mission Therapeutics
2023-06-28
40
2023-06-28
40
Andy Whiting, Nevrargenics
2023-06-21
34
2023-06-21
34
Ross Breckenridge, Arjuna Therapeutics
2023-06-14
39
2023-06-14
39
Jonathan Steckbeck, Peptilogics
2023-05-31
35
2023-05-31
35
Steve Trim, Venomtech
2023-05-24
33
2023-05-24
33
Tomas Dias, Mursla
2023-05-17
38
2023-05-17
38
Samantha Dale Strasser, Pepper Bio
2023-05-10
30
2023-05-10
30
Nara Daubeney, Phaim
2023-04-26
27
2023-04-26
27
Richard Weaver
2023-04-19
34
2023-04-19
34
Nuno Madeira do Ó, Reflection Therapeutics
2023-04-12
51
2023-04-12
51
Leigh Brody, AlbionVC
2023-03-29
39
2023-03-29
39
Samuel Woodhouse, CoSyne Therapeutics
2023-03-22
28
2023-03-22
28
Get this podcast on your
phone, FREE
